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Summary Principles: Quorum sensing (QS) regulation appears to be a consequence of
interbacterial communication by which bacteria of one or even different species learn
about their current population density and react in a deﬁned way to that information.
QS-regulation is a three step process: in the ﬁrst step speciﬁc signaling molecules
are produced and secreted to the exterior space. In the second step, the molecules
accumulate e.g. with growing population density. In the last step, a supra-threshold
concentration of the molecules is extra- or intra-cellularly sensed by the bacteria and
leads to a cascade of regulatory activities. While Gram-negative bacteria can employ
ﬁve or more different chemical classes of signaling molecules, Gram-positive cocci
predominantly use special oligopeptides for speciﬁc signaling.
Descriptions: Examples of QS-regulatory effects on virulence factor expression in
Staphylococcus aureus, Streptococcus mutans, and Enterococcus faecalis are given. In
these bacteria, QS-regulation appears to be crucial for displaying tissue invasiveness
and/or bioﬁlm formation.
Applications: The high speciﬁcity of the initial signal sensing and the importance
for expressing special virulence traits make this type of gene expression control a
promising target for the development of novel therapeutics. The options for such
therapies are critically discussed based on practical experiences with interference in
S. aureus QS-regulation.
© 2003 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Quorum sensing regulation — an
introduction
Bacteria colonizing the human skin and mucous
membranes share a common feature; that is their




capability for speciﬁc adherence to such surfaces.
To cause an infection, pathogenic bacteria will
eventually use additional mechanisms such as the
production of aggressive molecules interfering with
host cell function and integrity as well as protective
molecules inhibiting or modulating the host de-
fense. The expression of the responsible virulence
factors such as adhesins, aggressins, and defensins
follows a step-wise pattern that is well controlled
at each step and at the transition to the next one.
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In recent decades it has been found that bac-
teria can speciﬁcally sense their environment and
react to it. In addition, they can also record their
own physiological status, e.g. growth phase, dupli-
cation time, and intracellular levels of nutrition-
ally relevant molecules and use this information
to adapt their virulence behavior. A decade ago
it became obvious that bacteria can also sense
the population density of their own kind and of
neighboring microorganisms and integrate this in-
formation into many regulatory circuits. Now it is
broadly accepted that bacteria can act as ‘herd
animals’ — this is relevant to their virulence,
susceptibility to, and even production of antibi-
otics. The ability of bacteria to sense a species- or
mixed population-speciﬁc cell density and subse-
quently to react with control measures resembles
a polling procedure. In such a process votes are
counted and once a predeﬁned number of votes
(a ‘quorum’) has been reached, consequent activi-
ties will follow. Therefore, this type of regulation
is now commonly termed ‘quorum sensing (QS)
regulation’.
Figure 1 The three steps in quorum sensing regulation. (1) In the ﬁrst step, the signaling molecules are produced
either by employing the intracellular machinery and subsequent outward-bound transport or by secreting a protease
and subsequent cleavage from bacterial or even adjacent host structures. The signaling molecules may stay bound
to the bacterial surface or could be secreted to the environment. (2) In the second step, the signaling molecules
accumulate outside the bacteria either due to the continuous production of a growing number of bacteria, a decrease
of available space even without further production of signaling molecules, or due to the vicinity of an impermeable
structure in combination with a low level production of the molecules. (3) In the third step, the signaling molecules
reach a threshold level, at which it is sensed at the bacterial surface or after passive or active passage through
the cell membrane by intracellular receptors. As a consequence, speciﬁc regulators will be activated and start their
quorum sensing control of gene expression. The ﬁgure was modiﬁed from a similar one by Leonard and Podbielski.106
The single steps are in part described by various references.18,21,23,33,107,108
The Zen of quorum sensing regulation —
three steps in cell-cell-signaling
QS-regulation can broadly be described as a
three step process (Figure 1). In the ﬁrst step, a
cell-speciﬁc signaling molecule is produced inside
the bacterial cell and is transported through the
bacterial envelope. Once outside, it (i) often dif-
fuses into the environment or (ii) less often, stays
bound to the surface of the producing cell. Poten-
tially, (iii) some molecules could even originate
from the bacterial surface, the environment, or
from host factors and could be liberated due to the
activity of a processing enzyme produced by the
bacteria.
In the second stage, the signaling molecules will
accumulate outside the bacteria. This accumula-
tion may be due to the production of the molecules
at a constant, or, in some instances, an increasing
rate by a growing number of bacteria per given vol-
ume. Putatively, two alternative mechanisms could
also lead to signaling molecule accumulation: (i)
irrespective of the production rate, a decreased
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available space for bacteria and signaling molecules
(e.g. uptake into phagosomes), and (ii) the appear-
ance of an impermeable structure in close vicinity
to the bacteria (e.g. the extracellular matrix of host
tissues).
All these events ﬁnally lead to the third step,
in which the signaling molecules are sensed by
the exposed bacteria. For this step, the bacteria
may use two-component sensor/regulator pairs.
In such systems, a membrane-integrated sensor
speciﬁcally binds the signaling molecules at the
external surface of the bacteria and only then
speciﬁcally interacts with an intracellular regula-
tor protein by starting a phosphorylation cascade;
alternatively, the signaling molecules will passively
diffuse through the membrane or will actively be
transported into the bacterial cell. Once inside,
they speciﬁcally bind to a regulator protein (for
references, see Figure 1).
Sensing of the signaling molecules can start as
soon as themolecules are modiﬁed and/or exported
from the producing bacterium. However, it is only
when the extracellular or, after re-uptake, intra-
cellular concentration of the molecules reaches a
Figure 2 Examples of signaling molecules used for bacterial quorum sensing regulation. The ﬁgure shows the names
and principal structures of quorum sensing molecules and lists their producers as well as their sensing mechanisms.
pre-deﬁned threshold level, that sensing of these
compounds results in regulatory cascades that can
affect the expression of a few or several hundred
genes.
Signaling molecules and types of
regulation
To date, at least ﬁve different classes of signal-
ing molecules have been identiﬁed. A signaling
molecule was ﬁrst identiﬁed by Eberhard et al. in
1981,1 when these authors were looking for the
‘autoinducer’ (AI) molecule that made Photobac-
terium ﬁsheri glow with bioluminescence once
these bacteria reached a certain density in the
light organs of some species of deep sea ﬁsh (e.g.
Japanese pine cone ﬁsh, Monocentris japonica;
Hawaian squid, Euprymna scolopes).
The AI molecules belong to the biochemical class
of acyl homoserine lactones (AHLs, Figure 2). The
AHLs have so far been demonstrated to be prod-
ucts of the Gram-negative proteobacteria. These
molecules are lipophilic, so those with a short
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side chain can freely diffuse through the bacterial
membrane. The majority or even all of them are
internally sensed. It has been found that AHLs are
used for speciﬁc interspecies communication (Pseu-
domonas aeruginosa to Burkholderia cepacia,2,3)
and may even be involved in virulence-associated
signaling between diverse biological kingdoms
(Pseudomonas aeruginosa to Candida sp.,4).
The heptyl-hydroxy-quinolones (PQSs) are simi-
lar to the AHLs with respect to size and lipophilic
nature. Again these molecules are exclusively pro-
duced by some Gram-negative bacteria (i.e. Pseu-
domonas spp.), diffuse freely through the bacterial
membrane, and are internally sensed. Although
these molecules have no intrinsic antibacterial ac-
tivity, they are chemically related to the quinolone
antibiotics. This could be the reason why several
members of this group of antibiotics (e.g. oﬂoxacin)
have the capacity to interfere with PQS-mediated
QS-signaling pathways.5
Chemically diverse from the ﬁrst two classes
are the AI-2 molecules, currently believed to be
furanosyl borate diesters according to an analy-
sis of the Vibrio harveyi AI-2 signaling pathway.6
Because many other bacterial species can inter-
act with the Vibrio harveyi AI-2 signaling pathway
and because the AI-2 modifying LuxS protein se-
quence is extremely conserved throughout the
bacterial kingdom, the AI-2 molecule is assumed
to be highly conserved and to be produced by
many if not all Gram-negative and Gram-positive
bacteria.7 In E. coli, AI-2-like molecules are ac-
tively transported into the bacterial cell by a
specialized ribose transporter8 and are internally
sensed. However, as yet, the existence of an addi-
tional membrane-located sensor system can not be
excluded.
Because of their conservation, AI-2-likemolecules
seem to be commonly used for interspecies commu-
nication. Their effect on regulatory pathways con-
trolled by special sigma transcription factors9 could
indicate that the message signaled by AI-2-like
molecules is the metabolic burden of a cell.
Alternatively, it has been proposed that AI-2-like
molecules could be toxic metabolic by-products.10
However, AI-2 has also been implicated in vir-
ulence gene regulation in an epidemiologically
important Gram-positive species, Streptococcus
pyogenes.11
The cyclic dipeptides (or diketo-piperazines) are
chemically diverse from the other three classes.
So far, they have only been identiﬁed in some
Gram-negative bacteria. Since they interact with
AHL-pathway regulators, it is believed that these
molecules freely diffuse through the bacterial
membrane and are sensed internally.12
Chemically related to the cyclic dipeptides are
members of the last class, the oligopeptides.
Data from experimental and/or in silico analy-
ses show that these molecules are produced by
Gram-negative and Gram-positive bacteria.13 In
Gram-positive bacteria, they are either exter-
nally sensed by two-component systems or actively
taken up by oligopeptide permeases and internally
sensed.
Oligopeptides used for signaling have to be ex-
ported and, thus, often rely on the function of
specialized export systems. Such exporters recog-
nize their target molecules by signature sequences
in their leader peptides, i.e. a double glycine mo-
tif immediately upstream of the ﬁrst amino acid
of the mature peptide. Oligopeptides are the most
important QS-signaling molecules in Gram-positive
bacteria and are discussed below in greater detail.
Speciﬁcity and kinetics of QS-regulation
Although experimentally conﬁrmed data are
still missing for many aspects, it appears that
QS-regulation is used throughout the bacterial king-
dom and does rely on deﬁned classes of chemically
diverse molecules. Since bacteria most commonly
exist within a bioﬁlm (i.e. a mass of bacteria and
extracellular substances both adhering to a sur-
face) and most bioﬁlms contain many different bac-
terial species, how can such bacteria discriminate
between their own signaling molecules and that of
other strains or species within the same bioﬁlm?
The key for discriminating different ‘languages’
is the speciﬁcity of binding between the signaling
molecule and the cognate receptor. To achieve
this speciﬁcity, members of all classes of sig-
naling molecules (probably except the AI-2-like
molecules) exhibit a high degree of sequence
and/or structure variability. The AHLs from differ-
ent species or strains differ by the length and/or
chemical derivation of their lipophilic side chains.
So even single cells of Pseudomonas aeruginosa
produce and speciﬁcally sense different types of
AHL molecules (e.g. the signaling molecules of the
Las- and Rhl-QS-systems) in parallel. Such signal-
ing molecules induce partially synergistic, partially
antagonistic overlapping regulatory circuits that
are obviously needed to ﬁne tune the expression
of especially secreted virulence factors, e.g. the
elastase and alkaline protease enzymes.
Oligopeptides from various species or strains
of one species differ by their size, i.e. number
of amino acid residues, sequences, and often by
post-translational modiﬁcations such as the in-
duction of internal cyclizations due to thioester
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formation. The enzymes for the post-translational
processing are located in the cell membrane and
are active during the outward-bound transport of
the molecules. This compartmentalization allows
the signal-producing cell to differentiate between
a signal molecule that has just been produced, and
another one that is taken up from the environment.
The counterpart of the speciﬁc signalingmolecule
is the receptor, which so far has always been char-
acterized as a protein. As has been described for
the enzyme/substrate interaction, the signaling
molecule is bound within a pocket in the receptor
molecule. This binding step can be rigorously spe-
ciﬁc, e.g. it allows the discrimination of at least
four strain-speciﬁc signaling molecules in Staphy-
lococcus aureus (see below).
It can also be of rather low speciﬁcity, leading
to an interaction of the cyclic dipeptides at high
concentrations with the AHL receptors12 or, at
lower concentrations, with eukaryotic dipeptide
signaling pathways.14 Both high and low signaling
speciﬁcity has its biological role by either support-
ing the survival of certain S. aureus strains in a
narrow niche in the presence of many competitors
(see below) or by being the basis for modulation of
prokaryotic-eukaryotic interactions.15
The consequences of the interaction of the
signaling molecule with its receptor vary. In the
case of the intracellular LuxR-type proteins of
Gram-negative bacteria, LuxR serves as both sensor
and regulator and the binding of the cognate AHL
signaling molecules directly activates such recep-
tors/regulators. Receptors for some oligopeptides
such as the competence-inducing (i.e. DNA-uptake)
pheromones of Bacillus subtilis or Streptococcus
pneumoniae are also membrane-associated. Here,
the binding of the signaling molecules activates the
receptor protein by inducing a kinase function. The
activated receptor will phosphorylate and thereby
activate another intracellular protein, which can
be a regulator or another kinase/phosphatase.
The latter process could be part of a phosphory-
lation cascade that involves the subsequent activa-
tion of three or more kinases and effector proteins.
Such cascade pathways are utilized by bacteria for
signal ampliﬁcation processes and the integration
of other signaling pathways with supporting or com-
peting qualities.
A well studied example for the integration of con-
tradicting information is the QS-regulated decision
process that B. subtilis cells go through to choose
between the states of competence and sporulation.
For DNA uptake, the bacteria need thin cell walls
and metabolic activity, while for spore formation
thick cell walls and the shut-down of metabolic ac-
tivity are needed. Depending on the signal strength
and timing of the oligopeptide used, one of the
signaling cascades is activated and simultaneously
blocks the other regulatory circuit by speciﬁc phos-
phatase activity.
Irrespective of the number of interspersed trans-
mitter or regulator proteins, a common step in
QS-regulation is the speciﬁc binding of the acti-
vated regulator protein to a binding site within the
promoter region of a dependent gene on the ge-
nomic DNA. If several genes are directly affected
by such a regulator, all corresponding promoters
contain a highly conserved binding box. Thus, once
such a binding box for QS-regulators has been iden-
tiﬁed for a given bacterial species and the genome
of this species has been completely sequenced,
all gene members of the respective regulon can
be identiﬁed by an in silico analysis. Such analy-
ses were performed for Pseudomonas aeruginosa
and Streptococcus pneumoniae and indicated that
up to several hundred genes could belong to the
Rhl/Las or Com regulons, respectively.
The kinetics of QS-regulation follow one out
of a few possible patterns (see Figure 3). The
simplest regulatory mode relies on a continuous
production of the signaling molecules by each
cell of the population. With an increasing num-
ber of cells per volume, the amount of signal-
ing molecules will increase in a linear fashion.
Once the signaling molecules accumulate above
a predetermined threshold level, QS-regulation
commences by up-regulating or, less often, by
down-regulating16 the transcription of dependent
genes. If the operon that encodes the signaling
molecules and the cognate processing enzymes,
sensors and regulators is part of the regulon (i.e.
an autoregulatory loop), the production of the sig-
naling molecules may exponentially increase once
the threshold concentration is reached. This regu-
latory mode allows a faster and stronger reaction
than the linear production kinetics of the signaling
molecules. In some QS-regulation circuits, the sig-
naling molecules could be actively degraded once
the threshold level has been passed.17 Provided
that the regulation depends on a constant presence
of the signaling molecules above the threshold
level, this type of regulation would allow an up- and
subsequent fast down-regulation of the dependent
genes.
Biological role of QS-regulation
Since it was discovered to be the regulatory mech-
anism responsible for the function of the light
organs in several deep sea ﬁsh, QS-regulation and
its physiological impact has been studied in great
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Figure 3 Kinetic patterns of quorum-sensing (QS) regulation. Quorum-sensing bacteria produce and secrete their
signaling molecules (bold line) in a linear (panel A) or exponential fashion (panel B). Once the extracellular signaling
molecule concentration reaches a predeﬁned, strain-speciﬁc threshold level (gray line), a regulatory response (dashed
line) will start. Paralleling the kinetic mode by which the signaling molecules are produced, the kinetic pattern
of this regulatory response could also be linear or exponential. However, depending on the involved regulatory
pathway, increasing amounts of signaling molecules could induce an increased (panels A and B) or decreased (panel
C) expression of dependent genes. An increasing concentration of enzymes that modify the signaling molecules during
the QS-regulatory process could result in an initially increased and subsequently decreased expression (panel D) of
QS-regulation dependent genes.
detail especially in Gram-negative bacteria. Be-
side its importance for Photobacterium ﬁsheri bi-
oluminescence, it was found to be important for,
amongst other effects, Pseudomonas aeruginosa
bioﬁlm formation, Agrobacterium tumefaciens
tumor induction in plants, Erwinia carbapenem
antibiotic production, Providencia antibiotic re-
sistance induction, and Proteus and Serratia con-
trol of their swarming capabilities. In addition,
QS-regulation has been associated with many
virulence traits in Gram-negative bacteria when
acting as a single species or, in bioﬁlms, as a com-
munity of various species. Readers are referred
to several excellent up-to-date reviews on these
subjects.18—26
In Gram-positive bacteria, QS-regulation is as-
sociated with the development of natural com-
petence (i.e. the uptake of foreign DNA) in S.
pneumoniae, endospore formation in B. subtilis
and the production of antibacterial peptides (i.e.
lantibiotics) in lactobacilli. According to current
knowledge, there is no evidence to show that these
QS-directed processes mean that Gram-positive
bacteria cause or sustain infections in humans.27—32
In a very recent review, profound doubts have
arisen as to whether QS-regulation is a sign of
interbacterial communication or whether it is
used by bacteria to assess diffusion parameters
and thus nutrient availability in their immediate
environment.33
Irrespective of the deeper biological sense of
QS-regulation, its effects on the virulence behavior
of several Gram-positive cocci that cause frequent
and important infections in humans are beyond
doubt. In the following sections, speciﬁc examples
of QS-regulation in Staphylococcus aureus, Entero-
coccus faecalis and Streptococcus mutans will be
given.
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QS-regulation and Staphylococcus aureus
invasiveness
Staphylococcus aureus is one of the most impor-
tant bacterial pathogens. It frequently causes pu-
rulent infections of the skin and the intradermal
glands. In addition, it affects the mucous mem-
branes of the respiratory and genito-urinary tract.
After haematogenic or lymphogenic spread, it may
cause abscesses in every tissue and organ of the
human body. Such disseminated infections are as-
sociated with a change of virulence behavior of the
bacteria. For superﬁcial infections, the bacteria
need to express adhesins and thus display a sessile
phenotype. For the spreading step, the bacteria
have to produce lytic enzymes and toxins but no
adhesins, thus they are in a ﬂotile state. To induce
circumscribed, deep-seated infections, the bacte-
ria need to change back to their sessile character.
The switching between the two states and the abil-
ity to cause metastatic infections is predominantly
controlled by QS-regulation.
The QS-regulator of many staphylococcal species
is encoded by the agr operon. The accessory gene
regulator was originally detected by Recsei et al.34
as a positive control mechanism for the secre-
tion of some exoproteins. In the following years,
several authors35–43 showed that agr is a four
Figure 4 General pathway of Agr-driven quorum sensing regulation in staphylococci. The core agr operon encodes
a processing enzyme (AgrB), the signaling molecules (AgrD), a sensor histidine kinase (AgrC), and a regulator (AgrA).
AgrD is processed into its active form (bold typed subsequence) and secreted by the activity of membrane-associated
AgrB. It is subsequently sensed by membrane-associated AgrC. This sensing leads to phosphorylation of AgrA (AgrA∼P).
The activated AgrA∼P directly or indirectly (?) interacts with the Agr-dependent promoters P2 and P3 and leads to
an increased transcription rate (+) from these promoters. This in turn leads to transcription of the RNAIII molecules
which controls dependent genes by an antisense mechanism. The regulon is not drawn to scale.
gene operon (Figure 4), in which agrB encodes a
membrane-associated protease, agrD the signal-
ing peptide, agrC a membrane-associated sensor
kinase and agrA the cytoplasmic regulator.
The operon is constantly transcribed from a low
activity promoter. This leads to the presence of low
amounts of the AgrD pre-pro-peptide. Due to its
N-terminal leader sequence, the pre-pro-peptide is
directed to the membrane and transported to the
exterior space. During the transport, the peptide is
N-terminally and C-terminally cleaved and folded
into a ﬁve amino acid intramolecular thiolactone
ring involving the activity of the AgrB processor.
The mature hepta- to nonameric peptide (AgrD
pheromone) accumulates in the cellular environ-
ment. Usually at the transition to the stationary
growth phase, the AgrD pheromone reaches a con-
centration above the threshold. Now interaction
of AgrD with the sensor kinase AgrC effectively
activates the AgrA regulator by phosphorylation.
The activated AgrA molecule directly or indirectly
induces dramatically increased transcription rates
of the P2 and P3 promoters upstream of the agr
operon. P2 activation leads to augmented agr
operon transcription (positive auto-regulatory loop,
thus, a signal ampliﬁcation and acceleration — see
above). P3 activation leads to increased transcrip-
tion of the RNAIII molecule. RNAIII appears to be
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the crucial effector for the regulation of depen-
dent genes, potentially by an antisense modulating
effect (i.e. binding to speciﬁc mRNA molecules and
affecting their stability and translation efﬁciency).
Using whole genome DNA arrays for hybridization
assays with mRNA of S. aureus wildtype and agr
mutant strains, the results of Dunman et al.44 sup-
port the ﬁndings of many authors concerning the
agr-dependent expression of deﬁned adhesins and
secreted enzymes or toxins.45—51
Agr exerts negative control on the expression of
the IgG-binding protein A and some outward-bound
transporters. It displays positive control on the ex-
pression of the capsule material, cytolysins, serine
proteases, lipases, esterases, and some inward-
bound transmembrane transport systems. Thus,
agr represses genes that encode factors impor-
tant for colonization and activates genes encoding
tissue-degrading factors. The net effect of this co-
ordinate gene expression control corresponds to the
postulated model of agr function in the metastatic
spreading of S. aureus in the human body.
In fact, S. aureus virulence behavior follows more
complicated patterns because there are additional
layers of regulatory control which modulate the agr
regulatory loop at the level of agr and at steps fur-
ther downstream.52—56
The importance of a functional agr for disease
progression and for the development of invasive in-
fections has been demonstrated in several animal
infection models such as murine arthritis and pneu-
monia as well as rabbit osteomyelitis, endocarditis,
and endophthalmitis.57—62
Consistent with the idea that agr function is im-
portant for the establishment of an infection but
does not support local persistence of the bacteria,
agr-mutant isolates more efﬁciently adhere to en-
dothelial cells, internalize into epithelial cells and
induce lower apoptosis rates in exposed eukaryotic
cells.63,64 In addition to these in vitro data, in vivo
agr transcription rates, i.e. in fresh isolates from
the sputa of cystic ﬁbrosis patients, were hardly
detectable.65 The 12 patients in this study were ex-
amined during routine visits to the clinic and there-
fore could be regarded as chronically colonized by
S. aureus.
According to their diverse agrD sequences, S.
aureus strains are currently assigned to four agrD
groups (I—IV) and S. epidermidis strains to another
two agrD groups. It was speculated that some of
this sequence variability could arise during an ex-
tended infection process and could be correlated
with an altered virulence potential of such per-
sistent strains.66,67 Simultaneous colonization or
infection with S. aureus strains producing different
AgrD molecules frequently results in interference
of one type of AgrD-related signaling with the sig-
naling of the other AgrD type (see below). The
interference phenomenon and the potential pres-
ence of additional genes in association with deﬁned
types of agrD genes could explain why S. aureus
strains belonging to one of the agrD groups are pre-
dominantly associated with special locations of col-
onization (vaginal colonization — agrD group I) and
a deﬁned subset of diseases (enterotoxin-mediated
disease and endocarditis — agrD groups I and II;
toxic shock toxin-mediated disease — agrD group
III, exfoliative toxin-mediated disease — agrD group
IV). In contrast, suppurative infections except en-
docarditis are not associated with a speciﬁc agrD
group.68—70
QS-regulation and pathogenic potential
of Streptococcus mutans
Streptococcus mutans belongs to the taxonomically
outdated group of ‘viridans streptococci’.71 Like
other members of this group (i.e. Streptococcus
sanguinis), Streptococcus mutans will persistently
colonize the surfaces of the oral cavity once it
has been passed predominantly from mother to
child.72,73 This feature relies on the capability of
the bacteria to speciﬁcally and ﬁrmly bind to the
tooth surface by protein adhesins and subsequently,
produce a water-insoluble, sticky extracellular ma-
trix of complex polysaccharides. The mixture of
adherent bacteria and matrix molecules form a
typical bioﬁlm.74
Like other streptococci, S. mutans can metab-
olize sugar only by fermentation. Unlike other
streptococci, S. mutans continues the fermenta-
tion process until high amounts of lactic acid (a
pH value close to 4) have been reached. The lactic
acid dissolves calcium ions present in the teeth and
results in formation of caries. This pathologic pro-
cess is the basis of one of the economically most
important diseases in industrialized countries. In
the last two years, it became evident that bioﬁlm
formation and acid tolerance of S. mutans are both
crucially associated with QS-regulation. S. mutans
was found to possess a QS-regulation system that
closely resembles the com regulon of S. pneu-
moniae. At one genomic locus there is a comCDE
operon encoding the ComC signaling peptide, the
membrane-associated ComD sensor kinase, and the
ComE regulator.75 At a different site, there is a
comAB operon that is translated into a transmem-
brane processor/transporter unit.76 Finally, at an-
other site the comX gene encodes a RNA polymerase
cofactor.77
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Figure 5 General pathway of the Com-driven quorum-sensing regulation in viridans streptococci. Unlike the other
quorum-sensing regulators in this article, the com regulon comprises several genes and operons located at different
loci of the streptococcal genome. The precursor of the signaling molecules, ComC, is processed and secreted by the
activity of the membrane-associated ComAB machinery. The competence stimulating peptide (CSP) interacts with
membrane-associated histidine kinase ComD. This interaction results in the phosphorylation of the regulator ComE
(ComE∼P). The activated regulator ComE∼P positively (+) stimulates the transcription rate of the Com-dependent
promoters (Pcom). This leads to the increased production of the alternative sigma factor ComX, which in turn by inter-
action with the RNA polymerase core enzyme results in differential transcription of many secondary Com-dependent
genes. The regulon is not drawn to scale.
As in S. pneumoniae, ComC is constantly pro-
duced and exported by ComAB, and reaches its
critical threshold concentration at cell densities
typical for early- to mid-log phase cells. Then
its sensing and the subsequent regulation by
ComD/ComE induces a positive autoregulatory loop
on comCDE and comAB transcription (i.e. a signal
ampliﬁcation and a regulatory acceleration). In ad-
dition, comX expression leads to an increased for-
mation of ComX-RNA polymerase complexes and,
as a consequence, to a more efﬁcient binding to
and transcription of genes with com-boxes in their
promoters (Figure 5). Using deﬁned S. mutans com
mutants, synthetic ComC signaling molecules and
the appropriate environmental conditions, Li et al.
showed in a series of experiments75,78,79 that the
com system exhibits the typical regulatory features
of a QS-regulatory unit and is a prerequisite for the
uptake of foreign DNA (natural competence). The
competence is more pronounced and simultane-
ously, the tolerance to pH values of 4 is better when
the cells live at a high cell density in a bioﬁlm.
Finally, a normal bioﬁlm will only be formed with a
functional com regulon. Thus, the com regulon ap-
pears to be a key player in the ability of S. mutans
to cause caries lesions.
QS-regulation and virulence factor
production in Enterococcus faecalis
Enterococci, and among them especially Entero-
coccus faecalis, constantly colonize the human
intestines, the respiratory tract and skin, for pro-
longed periods without causing diseases. At these
locations, they are of prominent medical impor-
tance because of their tendency to harbor multiple
antibiotic resistance genes and their remark-
able ability to exchange these genes with other
enterococci and closely as well as distantly re-
lated Gram-positive and Gram-negative bacterial
species. Based on epidemiological data, entero-
cocci are potentially the most important transmit-
ters of antibiotic resistance genes.80
In a situation with new local (such as disturbed
surface structures) or general predisposing factors
(such as altered innate or acquired immunity) and
the distribution of enterococci into unusual com-
partments of the human body (e.g. by translocation
through damaged intestinal walls or catheterization
of the urinary tract), enterococci can cause endo-
carditis or cystitis which resist many established an-
tibiotic therapy regimens. Enterococcal virulence
factors include several secreted toxins (cytolysins)
90 A. Podbielski, B. Kreikemeyer
Figure 6 General pathway of the Fsr-driven quorum-sensing regulation in enterococci. After its production, the
FsrB protein undergoes an autoprocessing step, in which the signaling molecules ‘gelatinase biosynthesis activating
pheromone’ (GBAP) is liberated from a C-terminal portion of the protein. After using a still undeﬁned pathway
of membrane passage, GBAP interacts with the membrane-associated FsrC histidine kinase, which leads to the
phosphorylation of the regulator FsrA (FsrA∼P). The activated regulator FsrA∼P in turn upregulates the transcription
of the fsrBC operon and the adjacent gelatinase-cysteine protease operon. Its activity on other genes needs to be
elucidated. The regulon is not drawn to scale.
and enzymes (serine protease, gelatinase), as well
as surface adhesins (enterococcal surface protein).
Using different molecular approaches (partial
genome sequencing, puriﬁcation of signaling pep-
tide), two groups independently showed that some
E. faecalis strains harbor the fsr (fecal strepto-
cocci regulator) regulon. It contains the fsrA, fsrB,
and fsrC genes (Figure 6) which exhibit signiﬁcant
sequence homology to the S. aureus agrBCA genes.
The fsrA gene is monocistronically transcribed into
a response regulator, and fsrB fsrC form an operon
which encodes the processing enzyme and a sensor
kinase, respectively. Different to the agr operon,
fsrB contains the signaling peptide as part of its
C-terminus and liberates the gelatinase biosynthe-
sis activating pheromone (GBAP) peptide probably
by auto-processing. Due to the accumulation of
GBAP at the transition from exponential to sta-
tionary growth phase, the gelE and sprE genes,
which are located immediately downstream from
the fsr regulon and encode a gelatinase and serine
protease, respectively, are induced. As opposed to
the agr system, the induction is directly performed
by the binding of FsrA to the respective promoters
and does not involve an effectory RNA.81—83 Fsr
mutants are less virulent in Caenorhabditis elegans
killing, mouse peritonitis and rabbit endophthalmi-
tis models.84—86 As measured by mRNA-speciﬁc real
time RT-PCR, the expression of fsrBC and subse-
quently, of gelE is induced during log-growth phase
and reduced in stationary growth phase when the
bacteria are cultured in serum as opposed to their
culture in urine or in an artiﬁcial growth medium.87
Thus, fsr could have a special role in bloodstream
infections. This view is supported by some epidemi-
ological data. While 67 of 95 non-selectively col-
lected E. faecalis strains carried an fsr locus,85 12
out of 12 endocarditis strains but only 10 out of 19
stool strains harbored the fsr locus.88 When the out-
come of the disease (e.g. bacteremia and mortal-
ity) is measured, the association may be less clear.
Despite using an indirect approach by screening for
gelatinase production, Vergis et al.89 were unable
to associate the presence/production of several
fsr-dependent virulence factors with mortality.
Independent of the fsr regulon, E. faecalis con-
trols production of cytolysin via QS-autoinduction.90
Details of this regulatory pathway and its signiﬁ-
cance for enterococcal diseases need to be clariﬁed
by future analyses.
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QS-regulation as a target for novel
therapeutic approaches
Any type of virulence regulator could be an at-
tractive target for new drugs to ﬁght bacterial
infections. Such an approach could have speciﬁc
advantages:
1. QS-regulation is species- or even strain-speciﬁc,
thus any interference should selectively inhibit
the pathogen but not the innocent bystander
ﬂora.
2. QS-regulation can be completely blocked with-
out affecting bacterial viability and growth ki-
netics and so an interference should exert less
selective pressure for the development of resis-
tance mutations compared with antibiotics.
3. In some pathogens, QS-regulation controls bi-
ological functions like the internalization into
eukaryotic cells. Thus administering a substance
that interferes with the QS-regulated eukary-
otic cell internalization could be a supplement
for conventional therapy with antibiotics that
exclusively act outside the eukaryotic cells (e.g.
-lactams, aminoglycosides).
Because of these special features, we will call
such QS-interfering molecules ‘‘antipathogene-
tics’’ in the remainder of this article. When de-
veloping antipathogenetics, S. aureus would be
a prime target, because (i) it is one of the most
important human pathogens, (ii) agr regulation is
already understood in great detail, and (iii) the
production of peptide homologues is technically
and economically feasible.
Interestingly, it was nature itself that guided and
directed research on agr interfering molecules.
Soon after detecting the different agrD groups, Ji
et al.91 found that AgrD molecules of one group
can suppress AgrD-mediated signaling in other
groups. This can be of therapeutic relevance, since
the simultaneous administration of heterologous
AgrD molecules or other peptides that interfere
with RNAIII activation results in decreased le-
sion size in mice that have been challenged by
intra-dermally administered S. aureus strains. Sim-
ilarly reduced lesion sizes were seen when using S.
aureus agr knock out mutants for the intradermal
infection.40,92,93
When looking for molecules that could compete
with AgrD in binding to the speciﬁc receptor, it was
found that any amino acid exchange affecting the
internal thiolactone structure or the sequence of
the N-terminal tail of AgrD had negative effects on
the signaling capabilities of this molecule.94,95 A
truncated AgrD that was reduced to the pentameric
internal thiolactone ring inhibited any AgrD signal-
ing in S. aureus. Therefore, Lyon et al.96 suggested
a model for AgrD interaction with the AgrC sensor
kinase. They showed that AgrD binding to the re-
ceptor site of the cognate AgrC sensor is a two step
process involving the thiolactone ring for a ﬁrst
binding event and the N-terminal tail for a second.
Offering different AgrD molecules or only the thi-
olactone structure blocks the ﬁrst binding site for
cognate AgrD molecules but does not activate the
sensor kinase because of the lack of the second
binding event.
The AgrD-inhibitory cross-talk probably also oc-
curs in vivo and could explain the preferential col-
onization of plastic material by coagulase-negative
staphylococci in a nosocomial setting. Otto et al.97
observed that S. epidermidis AgrD interferes with
S. aureus agrD signaling. This inhibition seemed
to be the reason why S. epidermidis is so much
more effective in colonizing artiﬁcial surfaces like
catheter lumina in spite of the capability of S.
aureus to form bioﬁlms on plastic material. Once
the S. aureus agr operon is mutated, such strains
become insensitive to heterologous signaling and
will now efﬁciently grow bioﬁlms on artiﬁcial
surfaces.98 This remarkable feature is not associ-
ated with an altered production of adhesins or ex-
opolysaccharides, but to a decreased secretion of
an agr-dependent surfactant that obviously inter-
feres with bioﬁlm formation in wildtype bacteria.
These ﬁndings demonstrate that there are many
obstacles to overcome before QS-regulation inter-
fering antipathogenetics can be used as alternative
therapeutics in staphylococcal infections.
Conclusions
Besides the examples shown above, other Gram-
positive cocci that are very important pathogens,
also seem to use QS-regulation to control their vir-
ulence factor production. Recently, a blp operon in
S. pneumoniae99 and a rgf operon in Streptococcus
agalactiae (group B streptococci)100,101 were found
to exhibit sequence and functional similarities to
QS-regulatory systems. In Streptococcus pyogenes
(group A streptococci), two potential QS-regulators
have been identiﬁed:
1. The fas regulon102 is present in every Strepto-
coccus pyogenes strain tested. It exhibits signiﬁ-
cant sequence similarity to the sensor/regulator
gene pair of the agr operon, involves a RNA
effector molecule and controls biological func-
tions similar to that of the agr system. However,
no fas signaling peptide has yet been identiﬁed.
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In contrast to agr, the fas system comprises two
different sensor kinases, indicating the con-
vergence of several signals into one regulatory
pathway. A simpler version of the fas regulon
devoid of one of the sensor kinase genes can be
found in group C and G streptococci.103
2. The sil regulon104,105 appears to be associated
with S. pyogenes strains that cause invasive
diseases or rheumatic fever. The sil locus is lo-
cated close to an IS1562 insertion sequence, by
which it can be integrated into a genome region
that is partially homologous to the S. pneu-
moniae blp sequence. The sil locus encodes
a sensor/regulator pair (SilAB), a ComAB-like
transporter/processor (SilED) and the SilC pep-
tide, which putatively acts as a signaling pep-
tide. Deletion of the silC gene or the silB sensor
kinase gene signiﬁcantly reduced the virulence
of the corresponding S. pyogenes mutants in a
mouse skin infection model but did not affect
the resistance to phagocytosis of the mutants in
human blood. In addition, the presence of the
sil locus appears to confer natural competence
on such S. pyogenes strains. Interestingly, the
simultaneous application of SilC to a challenge
with S. pyogenes strains that carry the SilAB
sensor/regulator pair protects the animals in
the established infection model.
Thus, QS-regulatory systems in Gram-positive
cocci apparently show a sequence, structural and
auto-regulatory diversity that clearly exceeds that
of AHL-associated QS-regulatory units in Gram-
negative bacteria. This diversity requires much
more research to understand the common basic
principles — if there are any — and the details
that make the difference. It may even turn out
that such systems do not support interbacterial
communication.33 However, it is now obvious that
important virulence traits, especially the tissue in-
vasiveness of Gram-positive cocci, depend on func-
tional QS-regulation. This dependence gives the sci-
entiﬁc community the opportunity to develop novel
therapeutics to ﬁght the severe infections caused
by Gram-positive cocci. Such options make it worth
investing the time and effort to understand the
diversity of QS-regulation in Gram-positive cocci.
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